Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47373)
CDC/NIH Web Information Database (32181)
CDC-Authored Genomics and Precision Health Publications Database (5878)
Precision Health Database (63675)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (676)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226516)
Epigenetic Epidemiology Publications Database (22789)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last data update: Apr 25, 2024
. (Total: 63675 Documents since 2012)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 1241 Records)
Next
Query Trace:
A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
Jin Ju Kim et al. Clin Lab 2024 70(4)
Similar articles in PubMed
Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
Shayan M Dioun et al. Am J Obstet Gynecol 2024
Similar articles in PubMed
Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico.
Fernanda Mesa-Chavez et al. JCO Glob Oncol 2024 10e2300417
Similar articles in PubMed
Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries.
Riccardo Oliva et al. Int J Gynecol Cancer 2024
Similar articles in PubMed
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
Sara Torres-Esquius et al. JAMA Netw Open 2024 7(4) e247811
Similar articles in PubMed
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.
Hadeel Assad et al. Breast Cancer Res Treat 2024
Similar articles in PubMed
The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?
Lauren Gima et al. Clin Colon Rectal Surg 2024 37(3) 133-139
Similar articles in PubMed
Variants in BRCA1/2 in a hospital-based cohort in Chile and national literature review.
Fernanda J Martin et al. Ecancermedicalscience 2024 181683
Similar articles in PubMed
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.
Ajoy Oommen John et al. Eur J Hum Genet 2024
Similar articles in PubMed
The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing?
Natalia Campacci et al. Front Psychol 2024 151306388
Similar articles in PubMed
Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
D Gareth Evans et al. Fam Cancer 2024
Similar articles in PubMed
[Return of Individual Genomic Results to Germline Pathogenic Variant Carriers of Hereditary Cancer in Population Based Cohort Study].
Kinuko Ohneda et al. Gan To Kagaku Ryoho 2024 51(3) 231-236
Similar articles in PubMed
EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
Trudi McDevitt et al. Eur J Hum Genet 2024
Similar articles in PubMed
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
Xin Wang et al. Clin Genitourin Cancer 2024 102052
Similar articles in PubMed
Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Mady Head et al. Womens Health Issues 2024
Similar articles in PubMed
Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GD-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.
Natalie Herold et al. J Genet Couns 2024
Similar articles in PubMed
Germline mutations of 4567 patients with hereditary breast-ovarian cancer spectrum in Thailand.
Chalermkiat Kansuttiviwat et al. NPJ Genom Med 2024 9(1) 9
Similar articles in PubMed
Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention.
Fangjian Guo et al. JAMA Netw Open 2024 7(2) e2356078
Similar articles in PubMed
Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments.
N Morrish et al. Med Decis Making 2024 272989X241227425
Similar articles in PubMed
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer.
Xia Wei et al. JAMA Netw Open 2024 7(2) e2355324
Similar articles in PubMed
Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 families
WK Ho et al, Lancet Regional Health, February 2024
Bioinformatics Architecture for Integrating Genomics Data into Electronic Health Records.
Mauricio Brunner et al. Stud Health Technol Inform 2024 310996-1000
Similar articles in PubMed
Talking about Familial Breast and Ovarian Cancer Risk-Evaluation of a Psychosocial Training Module for Gynecologists in Germany.
Friederike Kendel et al. Cancers (Basel) 2024 16(2)
Similar articles in PubMed
Ten-Year Follow-Up of Women at High Risk for Familial Breast and Ovarian Cancer in Otago and Southland, New Zealand.
Simone Petrich et al. Asian Pac J Cancer Prev 2024 25(1) 3-7
Similar articles in PubMed
Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for BRCA1/2.
Giovanni Innella et al. J Med Genet 2023
Similar articles in PubMed
Prophylactic Interventions for Hereditary Breast and Ovarian Cancer Risks and Mortality in BRCA1/2 Carriers.
Taoran Liu et al. Cancers (Basel) 2024 16(1)
Similar articles in PubMed
Combined population genomic screening for three high-risk conditions in Australia: a modelling study.
Paul Lacaze et al. EClinicalMedicine 2024 66102297
Similar articles in PubMed
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand: a cost-effective policy in resource-limited settings.
Pongtawat Lertwilaiwittaya et al. Front Public Health 2024 111257668
Similar articles in PubMed
Risk-reducing decisions regarding germline BRCA pathogenic variant: focusing on the timing of genetic testing and RRSO.
Akiko Abe et al. J Med Genet 2023
Similar articles in PubMed
Recontact to return new or updated PALB2 genetic results in the clinical laboratory setting.
Seema Panchal et al. J Med Genet 2023
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 25, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP